PRES/S GENE MUTATION PROFILE OF HEPATITIS B VIRUS IN HBSAG-POSITIVE ETHNIC MINORITY POPULATIONS IN THAI NGUYEN

Nhị Hà Vũ, Thị Mỹ Bình Ngô, Đăng Tùng Nguyễn, Văn Cường Dương

Main Article Content

Abstract

Objective: To describe the genotype characteristics and mutations in the PreS/S region of the hepatitis B virus (HBV) in HBsAg-positive ethnic minority university students in Thai Nguyen, Vietnam. Materials and Methods: A cross-sectional descriptive study was conducted on 272 serum samples collected in 2024 from ethnic minority university students. Samples were screened for HBsAg using a rapid test and quantified for anti-HBs and anti-HBc using ELISA. HBV DNA was extracted, and the PreS/S region was amplified using nested PCR, sequenced via Sanger sequencing, and analyzed for mutations using BioEdit, MEGA 11, and Geno2pheno software. Results: HBV DNA was detected in 5 out of 272 samples (1.8%), all of which were from female participants belonging to the Dao and Tay ethnic groups, with HBsAg positivity and anti-HBs levels ranging from 0 to 13.9 mIU/mL. Phylogenetic analysis revealed that 2 samples belonged to genotype B and 3 to genotype C. A total of 21 mutation sites were identified in the PreS/S region, many of which were missense mutations. Notably, the L109P, S117N, and K122R mutations were located near the “a determinant” region, potentially affecting the surface structure and antigenicity of HBsAg. Conclusion: This study recorded genetic diversity of HBV genotypes B and C accompanied by characteristic PreS/S mutations among HBsAg-positive ethnic minority students. Some mutations may be associated with alterations in HBsAg antigenic structure, providing a basis for future research on the performance of HBsAg detection assays and mechanisms of HBV immune escape.

Article Details

References

World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024.
2. Tshiabuila D, San JE, Wilkinson E, Dor G, Tegally H, Maponga TG, et al. Conserved recombination patterns across hepatitis B genotypes: a retrospective study. Virology Journal. 2025;22(1):220.
3. Sedohara A, Takahashi K, Tsutsumi T, Arai K, Nakahara F, Ikeuchi K, et al. Characterization of genetic mutations in hepatitis B virus isolated from HBsAg+/HBcAb+/HBsAb–/HBV DNA+ Japanese blood donors. Scientific Reports. 2025;15(1):31265.
4. Anderson M, Phinius BB, Phakedi BK, Mudanga M, Bhebhe LN, Tlhabano GN, et al. Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana. Frontiers in Microbiology. 2024;15:1342862.
5. Liu H, Chen S, Liu X, Lou J. Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients. Virology Journal. 2024; 21(1):92.
6. Mbencho MN, Hafza N, Cao LC, Mingo VN, Achidi EA, Ghogomu SM, et al. Incidence of occult hepatitis B infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon. PLoS One. 2024;19(10):e0312126.
7. Mo Y, Jin F, Li D, Zou W, Zhong J, Tong Z, et al. Prevalence and molecular characteristics of occult hepatitis B virus infection among blood donors in Huzhou City, eastern China. Gene. 2024;927:148718.
8. Abechi P, George UE, Adejumobi OA, Ahmad U, Aborisade OY, Oragwa AO, et al. Evolutionary insights of hepatitis B virus genotypes and profiles of mutations in surface and basal core promoter/pre-core genes among HBsAg-positive patients in North-Central and Southwestern Nigeria. Viruses. 2025;17(8):1101.